基本信息
views: 4
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Mieke Van Hemelrijck leads the Translational Oncology and Urology Research (TOUR) Team in the School of Cancer & Pharmaceutical Sciences at King's. She became a Reader (Associate Professor) in Cancer Epidemiology in September 2018, and became a Professor in late 2020. She joined the Group in August 2008 from Harvard School of Public Health to study for her PhD on 'Metabolic Syndrome and Prostate Cancer: Biomarkers and Treatment Side-effects', which she completed in November 2010. At Harvard, her Master's thesis focused on bladder cancer and smoking patterns, building on her Master's in Statistical Data-Analysis received from Ghent University in her home country of Belgium in 2006.
As a cancer epidemiologist working with national registers and hospital-based (biobank) data in the UK and Europe, Prof Van Hemelrijck has expertise in clinical data, statistics, clinical practice and patient care in the area of uro-oncology. Moreover, several of her PhD students and staff are conducting qualitative research into understanding patients’ needs and experiences (e.g. development of educational support tool for men with prostate cancer on active surveillance; development of an exercise intervention as part of standard care for men with prostate cancer). Furthermore, Prof Van Hemelrijck has worked with Movember on developing a consensus document on semantics in active surveillance for men with prostate cancer using a modified Delphi consensus procedure. Most recently, Prof Van Hemelrijck started working with the European Association of Urology (EAU) Guidelines Office as part of the EU-funded PIONEER Consortium – big data for prostate cancer. She is leading the work package that aims to develop standardised definitions of prostate cancer outcomes among different stakeholders using the Delphi consensus procedure. Prof Van Hemelrijck’s prostate cancer research is internationally recognised and she is currently also involved in another large international Consortim: ReIMAGINE
Given Mieke’s interest in clinical epidemiology of urological cancers, she has coordinated the King’s Health Partners' Uro-Oncology Programme, which brings together all researchers and clinicians involved in urological cancer research at KHP since 2012. In 2013, she became a Visiting Researcher at the Institute of Environmental Medicine, Karolinska Institute, Stockholm, funded by a Swedish Council for Working Life and Social Research Fellowship.
Since 2008, Mieke has supervised more than 40 postgraduate and undergraduate students at King's, as well as being first supervisor currently for three PhD students in the TOUR team. Her teaching experience covers the two BSc Modules (Principles of Epidemiology and Sports, Exercise, Health, and Medicine I) hosted by the Faculty of Life Sciences and Medicine. She has published more than 240 original articles, of which she is first author on over 40 and last author on over 100.
As a cancer epidemiologist working with national registers and hospital-based (biobank) data in the UK and Europe, Prof Van Hemelrijck has expertise in clinical data, statistics, clinical practice and patient care in the area of uro-oncology. Moreover, several of her PhD students and staff are conducting qualitative research into understanding patients’ needs and experiences (e.g. development of educational support tool for men with prostate cancer on active surveillance; development of an exercise intervention as part of standard care for men with prostate cancer). Furthermore, Prof Van Hemelrijck has worked with Movember on developing a consensus document on semantics in active surveillance for men with prostate cancer using a modified Delphi consensus procedure. Most recently, Prof Van Hemelrijck started working with the European Association of Urology (EAU) Guidelines Office as part of the EU-funded PIONEER Consortium – big data for prostate cancer. She is leading the work package that aims to develop standardised definitions of prostate cancer outcomes among different stakeholders using the Delphi consensus procedure. Prof Van Hemelrijck’s prostate cancer research is internationally recognised and she is currently also involved in another large international Consortim: ReIMAGINE
Given Mieke’s interest in clinical epidemiology of urological cancers, she has coordinated the King’s Health Partners' Uro-Oncology Programme, which brings together all researchers and clinicians involved in urological cancer research at KHP since 2012. In 2013, she became a Visiting Researcher at the Institute of Environmental Medicine, Karolinska Institute, Stockholm, funded by a Swedish Council for Working Life and Social Research Fellowship.
Since 2008, Mieke has supervised more than 40 postgraduate and undergraduate students at King's, as well as being first supervisor currently for three PhD students in the TOUR team. Her teaching experience covers the two BSc Modules (Principles of Epidemiology and Sports, Exercise, Health, and Medicine I) hosted by the Faculty of Life Sciences and Medicine. She has published more than 240 original articles, of which she is first author on over 40 and last author on over 100.
Research Interests
Papers共 539 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL AND EXPERIMENTAL ALLERGYno. 4 (2024): 297-299
European Radiologypp.1-14, (2024)
Eleni Josephides, Roberta Dunn, Mona Faranghi, Annie-Rose Henry,John Pilling,Karen Harrison-Phipps,Shahreen Ahmad,Michael Skwarski,Benjamin Taylor,James Spicer,Alexandros Georgiou,Sharmistha Ghosh,
Lung Cancer (2024): 107687
Rossella Nicoletti,Juan Gomez Rivas,Laura Ibáñez, Carl Steinbeisserc,Bertrand de Meulder, Lyon France,Asieh Golozar,Susan Evans Axelsson,Robert Snijder,Anders Bjartell,Philip Cornford,Mieke Van Hemelrijck,
Michelle C. Turner,Urszula Radzikowska,Denisa E. Ferastraoaru,Mariona Pascal,Pieter Wesseling, Alexandra Mccraw, Claudine Backes,Heather J. Bax,Christoph Bergmann,Rodolfo Bianchini,Luigi Cari,Leticia de las Vecillas,
ALLERGYno. 6 (2024): 1419-1439
Aaditya Sinha, Zhane Peterson,Belul Shifa, Hannah Jeffery,Patriek Jurrius,Sarah Allen, Eugene Lee, Mohammed Azmat, Rachel Barrass,Damion Bailey,Jessica Johnson,Kathryn Adamson,
Radiology Advances (2024)
Maria Jose Monroy-Iglesias,Sabine Martin, Carlos Cargaleiro,Geraint Jones,Lindsay Steward,Colette Murtagh,Flaminia Bruno,Juliet Millwaters,Alexis Schizas, Harriet Watson,Anna Haire,Kate Haire,
BMJ Openno. 4 (2024): e080285-e080285
Nicoletti R.,Gomez Rivas J.,Ibánez L., Steinbeisse C.,de Meulder B.,Ayman H.,Golozar A.,Snijder R.,Van Hemelrijck M.,Beyer K.,Willemse P-P., Murtola T.,
European Urology (2024): S1579-S1580
Frontiers in Oncology (2024): 1334183-1334183
Julia Steinberg,Suzanne Hughes,Harriet Hui,Matthew J. Allsop,Sam Egger,Michael David,Michael Caruana, Peter Coxeter,Chelsea Carle,Tonia Onyeka, Isabel Rewais,Maria J. Monroy Iglesias,
Load More
Author Statistics
#Papers: 541
#Citation: 8909
H-Index: 49
G-Index: 81
Sociability: 8
Diversity: 4
Activity: 300
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn